BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30073947)

  • 1. Licensing and Approval of Antimicrobial Agents for Use in Animals.
    Pomba C; Catry B; Edo JT; Jukes H
    Microbiol Spectr; 2018 Aug; 6(4):. PubMed ID: 30073947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance and the guidelines of the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).
    Marion H
    Rev Sci Tech; 2012 Apr; 31(1):299-306. PubMed ID: 22849284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(3):603-5. PubMed ID: 12365425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome.
    Cerniglia CE; Pineiro SA; Kotarski SF
    Drug Test Anal; 2016 May; 8(5-6):539-48. PubMed ID: 27443209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standards of the in vitro mutation frequency study and the antimicrobial activity study in gut.
    Fukuyasu T; Igimi S; Uchida K; Eguchi M; Endo T; Oshima S; Kuwano A; Sawada T; Tamura Y;
    J Antibiot (Tokyo); 2003 Feb; 56(2):190-6. PubMed ID: 12715882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International harmonisation of anthelmintic efficacy guidelines (Part 2).
    Vercruysse J; Holdsworth P; Letonja T; Conder G; Hamamoto K; Okano K; Rehbein S;
    Vet Parasitol; 2002 Feb; 103(4):277-97. PubMed ID: 11777607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International harmonisation of regulatory requirements.
    Holmes M; Hill RE
    Rev Sci Tech; 2007 Aug; 26(2):415-20. PubMed ID: 17892161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsibilities of regulatory agencies in the marketing of antimicrobials.
    Grein K
    Rev Sci Tech; 2012 Apr; 31(1):289-98. PubMed ID: 22849283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Pharmacopoeia (EP), USDA and MAFF standards--will they ever be harmonised under the VICH umbrella?
    Castle P
    Dev Biol (Basel); 2005; 121():227-34. PubMed ID: 15962485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Resistance: a One Health Perspective.
    McEwen SA; Collignon PJ
    Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29600770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control programmes for veterinary antimicrobial medicines.
    Ponte H; Ivo RS; Silva-Lima B; Ramos F
    Regul Toxicol Pharmacol; 2018 Nov; 99():1-4. PubMed ID: 30130551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the development and prevalence of antimicrobial resistance in bacteria of food animal origin in Japan: a new approach for risk management of antimicrobial veterinary medicinal products in Japan.
    Asai T; Hiki M; Ozawa M; Koike R; Eguchi K; Kawanishi M; Kojima A; Endoh YS; Hamamoto S; Sakai M; Sekiya T
    Foodborne Pathog Dis; 2014 Mar; 11(3):171-6. PubMed ID: 24387636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of product characteristic: the next step to harmonization registration requirements for veterinary medicinal products in Poland.
    SztabiƄska-Koncka H
    Regul Toxicol Pharmacol; 2000 Jun; 31(3):311-2. PubMed ID: 10915591
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of antimicrobial resistance on regulatory policies in veterinary medicine: status report.
    Tollefson L; Flynn WT
    AAPS PharmSci; 2002; 4(4):E37. PubMed ID: 12646009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing new regulatory approaches to antimicrobial safety.
    Tollefson L
    J Vet Med B Infect Dis Vet Public Health; 2004; 51(8-9):415-8. PubMed ID: 15525377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance and the standards of the World Organisation for Animal Health.
    Orand JP
    Rev Sci Tech; 2012 Apr; 31(1):335-42, 325-34. PubMed ID: 22849287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International harmonisation of anthelmintic efficacy guidelines.
    Vercruysse J; Holdsworth P; Letonja T; Barth D; Conder G; Hamamoto K; Okano K;
    Vet Parasitol; 2001 Apr; 96(3):171-93. PubMed ID: 11240092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.